Endometriosis Market - Trends Forecast Till 2028

Market Overview

The global endometriosis market is anticipated to reach USD 1.9 billion by 2020 growing at a CAGR of 2.7% during the forecasting period, 2020-2028. Endometriosis is the disease of adolescents and reproductive-aged women characterized by the presence of endometrial tissue outside the uterine cavity and is commonly associated with chronic pelvic pain and infertility. Factors such as the high prevalence of endometriosis among the female population of reproductive age and increasing female population within the age group of 15-49 years across developed as well as developing economies are some of the major drivers for endometriosis market

Key Findings

The global endometriosis market is segmented into tests, treatment, stages, end-users, and geography.

Tests segment is segmented into Pelvic Exam, Ultrasound, Magnetic Resonance Imaging (MRI), and Laparoscopy

The treatment segment is segmented into Pain Medication, Hormone Therapy, Surgery. Pain Medication is further segmented into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Ibuprofen (ADVIL, MOTRIN IB, Others), Naproxen Sodium (ALEVE, Others). The hormone therapy segment is further segmented into Hormonal Contraceptives, Gonadotropin-Releasing Hormone (GN-RH) Agonists And Antagonists, Progestin Therapy, Aromatase Inhibitors. Surgery is further segmented into Conservative Surgery, Hysterectomy, and Oophorectomy.

Stages segment is segmented into Stage I, Stage II, Stage III, and Stage IV

End Users segment is segmented into Hospitals, Surgical Centers, Specialty Centers, and Others

Geographically, the global endometriosis market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions 

Regional Analysis

North America region is the largest contributor to the endometriosis market in the forecast period 2020-2028 and the Asia-Pacific region is expected to grow with the highest CAGR during the forecast period 2020-2028.

Competitive Landscape

Key players in the global endometriosis market are AstraZeneca, Bayer AG, Neurocrine Biosciences, Inc., Meditrina Pharmaceuticals Inc., among others

Recent Developments

The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:

• In 2018, Bayer has announced a collaboration with Evotec announced phase I trials of new small molecules for the treatment of endometriosis

Hence, tremendous progress has been made over the last decade and yet a lot more to come in recent years.

Reasons to Acquire

• Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors
• Gain authentic and granular data access for the endometriosis market so as to understand the trends and the factors involved in changing market situations
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope